OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 4 of 45

5   ➤ Diagnostic Criteria and Laboratory Interpretation • Prediabetes is def ined as a fasting plasma glucose level of 100–125 mg/dL, a 2-hour plasma glucose level of 140–199 mg/dL, or a hemoglobin A1c level of 5.7% to 6.4%.   ➤ The diagnosis of T2DM requires one of the following criteria: • Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) • 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test • Hemoglobin A1c ≥6.5% (48 mmol/mol) • Or random plasma glucose ≥200 mg/dL with classic symptoms of hyperglycemia.   ➤ The oral glucose tolerance test remains the gold standard for diagnosing glucose intolerance, though hemoglobin A1c provides valuable information about average glycemic control over two to three months.   ➤ A Finnish Diabetes Risk Score (FINDRISC) score ≥12 indicates a high risk of T2DM. Noninvasive biomarkers of insulin resistance, such as the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) >2.0, may also indicate a risk of T2DM. Most sources suggest a cutoff of greater than 2.0 for insulin resistance; however, some studies suggest a cutoff of greater than 2.5.   ➤ The triglyceride-glucose (TyG) index had an error in its initial publication, leading to two different formulas being used in the literature: • TyG = Ln (fasting triglycerides × fasting plasma glucose) ÷ 2; cutoff ≥4.5 = insulin resistance. • TyG = Ln (fasting triglycerides × fasting plasma glucose ÷ 2); cutoff ≥8.5 = insulin resistance.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026